Yan D - Search Results

1

Metabolism Pathways of Major Therapeutics for Treating Monkeypox Mono- and Co-infection with Human Immunodeficient Virus or SARS-CoV-2.

Yan D, Yan B. Yan D, et al. Among authors: yan b. Curr Drug Metab. 2023;24(4):240-249. doi: 10.2174/1389200224666230607124102. Curr Drug Metab. 2023. PMID: 37287302 Free PMC article. Review.

2

The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance.

Yan D, Ra OH, Yan B. Yan D, et al. Among authors: yan b. Anim Dis. 2021;1(1):15. doi: 10.1186/s44149-021-00017-5. Epub 2021 Sep 7. Anim Dis. 2021. PMID: 34778881 Free PMC article. Review.

3

Viral target and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: Molnupiravir, nirmatrelvir, and remdesivir.

Yan D, Yan B. Yan D, et al. Among authors: yan b. Fundam Clin Pharmacol. 2023 Aug;37(4):726-738. doi: 10.1111/fcp.12889. Epub 2023 Mar 25. Fundam Clin Pharmacol. 2023. PMID: 36931725 Free PMC article. Review.

4

A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity.

Guo L, Panderi I, Yan DD, Szulak K, Li Y, Chen YT, Ma H, Niesen DB, Seeram N, Ahmed A, Yan B, Pantazatos D, Lu W. Guo L, et al. Among authors: yan dd, yan b. ACS Nano. 2013 Oct 22;7(10):8780-93. doi: 10.1021/nn403202w. Epub 2013 Oct 1. ACS Nano. 2013. PMID: 24053214 Free PMC article.

5

Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles.

Guo L, Yan DD, Yang D, Li Y, Wang X, Zalewski O, Yan B, Lu W. Guo L, et al. Among authors: yan dd, yan b. ACS Nano. 2014 Jun 24;8(6):5670-81. doi: 10.1021/nn5002112. Epub 2014 May 13. ACS Nano. 2014. PMID: 24801008 Free PMC article.

6

Yinchen-Gancao decoction ameliorated NASH in mice by reducing hepatic lipid accumulation, inhibiting hepatic inflammatory and endoplasmic reticulum stress.

Zhao J, Jin J, Li Y, Zhang S, Li F, Cui J, Wang Z, Yan D, Qiu F. Zhao J, et al. Among authors: yan d. J Ethnopharmacol. 2025 Jan 2:119318. doi: 10.1016/j.jep.2025.119318. Online ahead of print. J Ethnopharmacol. 2025. PMID: 39755186

7

MPIC: Exploring alternative approach to standard convolution in deep neural networks.

Jiang J, Zhong Y, Yang R, Quan W, Yan DM. Jiang J, et al. Among authors: yan dm. Neural Netw. 2024 Dec 30;184:107082. doi: 10.1016/j.neunet.2024.107082. Online ahead of print. Neural Netw. 2024. PMID: 39754840

8

Targeting uric acid: a promising intervention against oxidative stress and neuroinflammation in neurodegenerative diseases.

Xu L, Li C, Wan T, Sun X, Lin X, Yan D, Li J, Wei P. Xu L, et al. Among authors: yan d. Cell Commun Signal. 2025 Jan 3;23(1):4. doi: 10.1186/s12964-024-01965-4. Cell Commun Signal. 2025. PMID: 39754256 Free PMC article. Review.

9

Clinical features and prognosis of anti-MDA5-positive dermatomyositis with coexistent anti-aminoacyl-tRNA synthetase antibodies.

Wang G, Yan D, Weng C, Xue L, Liu Z. Wang G, et al. Among authors: yan d. Clin Rheumatol. 2025 Jan 3. doi: 10.1007/s10067-024-07298-4. Online ahead of print. Clin Rheumatol. 2025. PMID: 39751977

10

Cationic Modification in Hybrid Iodates: A Pathway to Superior Performance.

Zhao JJ, Li SF, Lv MH, Wang JX, Tang RL, Huang H, Zhang B, Yan D. Zhao JJ, et al. Among authors: yan d. Inorg Chem. 2025 Jan 3. doi: 10.1021/acs.inorgchem.4c05135. Online ahead of print. Inorg Chem. 2025. PMID: 39749924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,022 results

Search Page

Filters